TNXP tonixpharma.com: Sotuvning operatsion marjasi

Tonix Pharmaceuticals Holding (TNXP) tovar belgisi

Tonix Pharmaceuticals (TNXP) portfeli nevrologiya va immunologiyani qamrab oladi, biroq binariy klinik sinovlar xavflari ostida qolmoqda. Formula sinergiyasi AQSh Mudofaa vazirligi markazlari bilan hamkorlik orqali yaratiladi. Operatsion foyda marjasi ichki samaradorlikni namoyish etadi, bunda ko'rsatkichning joriy darajasi -436.20 ni tashkil etadi. Biznes sog'liqni saqlash tizimlari va dorixona zanjirlari uchun vaksinalar hamda fibromialgiya davolash vositalarini ishlab chiqishga tayanadi.

TNXP - Tonix Pharmaceuticals Holding Corp. Operatsion foyda normasi 04.07.2022 - 20.11.2026 oraligʻida

Tonix Pharmaceuticals - tahliliy kesimlar va asosiy koʻrsatkichlar (TNXP)

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning asosiy tahlili:TNXP, Tonix Pharmaceuticals Inc.
Tonix Pharmaceuticals Holding tayyor mahsulotlari

Operatsion marja moliyaviy xarajatlar va soliqlarni hisobga olishdan oldin, umumiy daromadga nisbatan asosiy operatsiyalardan olingan foyda ulushini o'lchaydi. Ushbu ko'rsatkich biznes modelining ichki samaradorligini va kompaniyaning pul oqimini yaratish qobiliyatini belgilaydi. Operatsion samaradorlik dinamikasini tahlil qilish orqali investor aktivlarning haqiqiy qiymatini aniqlashi mumkin. Tonix Pharmaceuticals (TNXP) uchun manfiy qiymatlar kritik likvidlik tanqisligini tasdiqlaydi, bu esa kompaniyani dori vositalarini bozorga chiqarishni moliyalashtirish uchun aksiyalar emissiyasiga bog'liq qiladi.

Tonix Pharmaceuticals raqobatchilari tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.